We are live on ! Find out more
RVM

RiverVest Venture Management Portfolio holdings

AUM $6.84M
1-Year Est. Return 7.71%
This Fund
S&P 500
This Quarter Est. Return
+3.91%
1 Year Est. Return
-7.71%
3 Year Est. Return
-16.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90.2M
AUM Growth
+$3.72M
Cap. Flow
+$1M
Cap. Flow %
1.11%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
OKUR
OnKure Therapeutics
OKUR
+$1.01M

Top Sells

Rank Stock Value
1
VAPO
Vapotherm, Inc. Common Stock
VAPO
+$3.01K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MIRM icon
1
Mirum Pharmaceuticals
MIRM
$6.08B
$41.9M 46.52%
1,621,118
– –
ALLK
2
DELISTED
Allakos
ALLK
$21.3M 23.64%
4,887,932
– –
OKUR
3
OnKure Therapeutics
OKUR
$155M
$16.6M 18.44%
253,422
+12,500
+5% +$1.01M
SPRB
4
Spruce Biosciences
SPRB
$182M
$6.31M 7%
39,150
– –
XLO icon
5
Xilio Therapeutics
XLO
$59.3M
$3.78M 4.19%
102,960
– –
VAPO
6
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$188K 0.21%
52,226
-656
-1% -$3.01K

Similar funds

JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KIM
Kaizen Investment Management Singapore $6.23M AUM
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
HVM
Harvest Volatility Management Norwalk, Connecticut $4.39M AUM 13.08% 1-Year Est. Return
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
QC
QCM Cayman Houston, Texas $3.63M AUM 61.13% 1-Year Est. Return
CU
Cornell University New York $3.44M AUM 9.69% 1-Year Est. Return
PWA
Pillar Wealth Advisors West Chester, Pennsylvania $3.35M AUM 22.3% 1-Year Est. Return

RiverVest Venture Management's Q2 2023 Portfolio in Review

As of Q2 2023, RiverVest Venture Management held 6 positions worth $90.2M, up 4.3% from $86.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 0%. RiverVest Venture Management opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • RiverVest Venture Management added most to OnKure Therapeutics in Q2 2023, an estimated $1.01M increase.
  • RiverVest Venture Management's biggest Q2 2023 reduction was Vapotherm, Inc. Common Stock, cutting an estimated $3.01K.
  • RiverVest Venture Management's ten largest holdings make up 100% of its $90.2M portfolio in Q2 2023.
  • RiverVest Venture Management opened 0 new positions and closed 0 in Q2 2023.
  • RiverVest Venture Management's portfolio value rose 4.3% quarter-over-quarter to $90.2M.

Based on RiverVest Venture Management's 13F filing for Q2 2023, filed 7 Aug 2023.